Obviously everyone would love to see us with a MC in the area of where Amarin is....right now its over $6.4 billion USD...even $5 billion USD would be awesome, our PPS would be up around $30 CDN at that level.  

Of course Amain didn't get anywhere near $5 billion until after they announced their Phase 3 results...just prior my best guesstimate puts their MC in and around $1 billion USD.  And that was with a drug that was already approved and generating sales....so comparing our $440 million USD market cap with Amarin's pre Reduce-IT valuation.....I don't think we're out of line, and that's even with us not having a US listing.